Chemicals and pharmaceuticals · CLVR

Clever Leaves Holdings Inc.

12 filings mentioning 6 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
6topics disclosed
Chemicals and pharmaceuticalsindustry
F8based in

Across 12 filings we hold, Clever Leaves Holdings Inc. has written down 6 of the topics we track. That places it 79 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

CLVR Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something Clever Leaves Holdings Inc. has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO 27001:202242
ISO 22301:201938
ASD Strategies to Mitigate Cyber Security Incidents29
DORA19
NIST SP 800-16115
COSO Internal Control9
NIST SP 800-615
PCAOB AS 22014
IFRS 172

10 frameworks, 241 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Material Weakness24
Internal Control24
Business Continuity4
Ransomware3
Restatement2
Third Party Risk Management1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Material Weakness242023-11-09
Internal Control242024-04-01
Business Continuity42021-11-10
Ransomware32022-03-24
Restatement22021-05-04
Third Party Risk Management12024-04-01

When it filed

Filings we hold, by year. Hover a bar for the count.

20
21
22
23
24

Recent filings

FiledFormItem
2024-04-018-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2024-04-0110-Kfiling
2023-11-098-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2023-08-248-KItem 3.03, Regulation FD disclosurefiling
2023-08-148-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2023-07-058-KEntry into a material agreement, Completion of an acquisition, Financial statements and exhibitsfiling
2023-05-118-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2023-03-308-KResults of operations, the earnings release, Delisting or listing rule failure, Financial statements and exhibitsfiling
2023-01-238-KItem 2.05, Material impairment, Regulation FD disclosurefiling
2023-01-238-KItem 2.05, Material impairment, Regulation FD disclosurefiling
2023-01-238-K/AItem 2.05, Material impairment, Regulation FD disclosurefiling
2022-11-098-KResults of operations, the earnings release, Financial statements and exhibitsfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition